The intestinal epithelial lining forms a physical barrier that prevents translocation of commensal microorganisms and defects in intestinal barrier integrity or maintenance have severe clinical impact (Konig et al., 2016; Peterson and Artis, 2014) . Loss of barrier function activates deleterious immune responses and the ensuing mucositis can lead to transmural ulcers and the need for parenteral nutrition (Sonis, 2004) . Such complications are a major dose-limiting side effect of high-dose chemotherapy for head-and-neck cancers or during myeloablative conditioning for hematopoietic stem cell transplantation as part of leukemia treatment (Keefe, 2007; Sonis, 2004) . Insufficient intestinal barrier repair is also a pathological feature underlying inflammatory bowel disease (IBD), including Crohn's disease and ulcerative colitis (Hollander et al., 1986; Odenwald and Turner, 2013) . Reduced barrier integrity evokes continuous bacterial translocation, fueling reactivation of microbiota-specific T cells and subsequent disease recurrence in up to 40% of IBD patients in remission (Munkholm et al., 1994) . Enhancing intestinal epithelial repair, also coined mucosal healing, has become a sought-after result in experimental and clinical IBD research, yet the cells and signals that enhance epithelial regeneration are still ill defined (Dulai et al., 2015; Florholmen, 2015; Neurath, 2014; Shah et al., 2016) .
In contrast to the potentially deleterious consequences of overt anti-bacterial immune activation following barrier loss, innate immune cell-derived signals are also implicated as positive regulators of intestinal regeneration (Aparicio-Domingo et al., 2015; Lindemans et al., 2015) . Group 3 innate lymphoid cells (ILC3s) safeguard epithelial stem cells after acute small intestinal damage inflicted by Methotrexate, mediated through production of IL-22 (Aparicio-Domingo et al., 2015) . IL-22 is constitutively produced by small intestinal ILC3 (Savage et al., 2017) , is important for homeostatic production of antimicrobial peptides (Liang et al., 2006) , and drives stem cell proliferation in organoid cultures ex-vivo (Lindemans et al., 2015) .
Intestinal repair is driven by epithelial stem cell differentiation, and subsequent proliferation of progenitor cells in crypts of Lieberkühn (Barker, 2014) . Crypt regeneration is regulated by highly conserved signaling pathways activated by signals from local niche cells (Kabiri et al., 2014; Medema and Vermeulen, 2011; Sato et al., 2011) . Wnt and Notch signals control stem cell self-renewal (Clevers et al., 2014) , while in addition, Wnt favors Paneth cell differentiation (Van Es et al., 2005) , while Notch controls the absorptive versus secretory lineage choice (Jones et al., 2015) . Hedgehog signaling is involved in progenitor proliferation (Van Dop et al., 2010) , while BMPs activate the pericryptal mesenchyme to support the epithelial stem cell niche (He et al., 2004) . The Hippo-YAP1 pathway is mostly active in response to damage, inhibiting Wnt and Notch signaling to drive early differentiation (Gregorieff et al., 2015; Imajo et al., 2015) . IL-22 was postulated to also be a stem cell niche factor, derived not from structural cell but from intestinal ILC3, and involved in intestinal repair (Hanash et al., 2012; Pickert et al., 2009) .
In this study, we set out to define the role of ILC3-derived IL-22 during epithelial repair and to mechanistically interrogate this process. We show that in response to acute small intestinal damage the stem cell protective cytokine IL-22 is dispensable for crypt cell proliferation and that in contrast, ILC3s modulate intestinal repair by controlling the amplitude of Hippo-YAP1 signaling. Yap1 activation involves signals downstream of gp130 and Src family kinases.
These findings unveil a unique layer of epithelial regulation, in which evolutionary conserved regenerative pathways are amplified by cells of the innate immune system. This realization paves the way for novel therapeutic strategies aimed at enhancing tissue repair during IBD or during cytotoxic anti-cancer therapies through activation of intestinal immune cells independent of the well-established effects of IL-22 (Hanash et al., 2012; Lindemans et al., 2015) .
RESULTS AND DISCUSSION

Crypt cell proliferation after stem cell damage is IL-22 independent
The ILC3-derived cytokine IL-22 positively impacts the percentage of Lgr5 + intestinal stem cells that can be recovered from small intestinal crypts after acute damage, and induces epithelial proliferation in vitro (Aparicio-Domingo et al., 2015; Lindemans et al., 2015) . To determine the importance of IL-22 for small intestinal regeneration we compared intestinal pathology and crypt cell proliferation after MTX-induced damage in IL-22 deficient mice and ILC3-deficient RORgt -/mice. As we have shown before (Aparicio-Domingo et al., 2015) , absence of ILC3 increased tissue pathology in response to MTX. In contrast, pathology in IL-22 deficient mice was similar to pathology of IL22-sufficient littermate controls ( Figure 1A) .
As a measure of crypt regeneration, we enumerated proliferating crypt cells during the regenerative phase of the response (day 4). This revealed that the severely reduced proliferation, characteristic of ILC3-deficiency (Aparicio-Domingo et al., 2015) , was absent from IL-22 -/animals, in which crypt proliferation was indistinguishable from littermate controls ( Figure 1B) . This led us to hypothesize that small intestinal crypt proliferation after acute MTXinduced damage can occur in an IL-22 independent manner, uncoupled from IL-22 dependent epithelial stem cell maintenance.
To test this hypothesis directly, we neutralized IL-22 by antibody treatment in Lgr5-GFP stem cell-reporter mice during exposure to MTX. This allowed for combined analyses of stem cell maintenance and crypt proliferation. Inhibition of IL-22 signaling was confirmed by downregulation of transcripts encoding the prototypic IL-22 target genes Reg3g and Reg3b ( Figure S1 ). Upon neutralization of IL-22 signaling with antibodies ( Figure 1C ) during tissue damage, maintenance of Lgr5-GFP-expressing cells was impaired. In contrast, crypt proliferation was unaffected ( Figure 1D ) and was similar to control animals. Together these data reveal that ILC3-dependent stem cell maintenance and crypt proliferation are mechanistically distinct responses to insult, and that the early proliferative response following small intestinal injury is IL-22 independent.
YAP1 signaling drives small intestinal regeneration
Given that small intestinal crypt proliferation occurred in an IL-22 independent manner, we set out to identify the epithelial repair programs activated by acute small intestinal damage. To this end, we analyzed changes in the epithelial stem cell transcriptome evoked by MTX immediately following induction of damage (day 1) and during regeneration (day 4). RNAsequencing of purified Lgr5-GFP hi crypt cells revealed rapid transcriptional induction of target genes of the regeneration-associated Hippo/YAP1 pathway, at one and four days after damage (Figure 2A YAP1 activates target gene transcription by binding to nuclear TEAD transcription factors (Zhao et al., 2008) . The interaction between YAP1 and TEADs can be inhibited by Verteporfin, an FDA-approved drug used for treatment of macular degeneration (Battaglia Parodi et al., 2016) . To resolve the importance of YAP1 activation for small intestinal regeneration after MTX-induced damage we blocked YAP1-TEAD interactions during MTX exposure. YAP1 inhibition increased tissue pathology, characterized by severe crypt abnormalities ( Figure 2H ) and a loss of crypt cell proliferation ( Figure 2I) , very similar to the loss of regeneration in ILC3deficient RORgt -/mice. Together these findings identify YAP1 activation as a dominant driver of early small intestinal crypt regeneration following acute damage.
YAP1 activation is blunted in the absence of ILC3
Based on the importance of YAP1 activation and ILC3 presence for small intestinal regeneration we hypothesized that activation of the Hippo/YAP1 pathway is controlled by ILC3 presence. To test this hypothesis, we analyzed YAP1 activation in mice lacking ILC3. In RORgt-deficient mice, damage-induced YAP1 nuclear translocation was strongly reduced Together these data reveal that the magnitude of the evolutionary conserved, regenerationassociated, Hippo-YAP1 pathway is amplified by presence of small intestinal ILC3.
Activation of YAP1 signaling in intestinal crypts is independent of IL-22
Our findings indicate that crypt proliferation and Lgr5 cell maintenance are independently regulated, fueled by YAP1 and IL-22 respectively. To assess whether IL-22 has a role in epithelial YAP1 activation after small intestinal damage we quantified YAP1 activation in epithelial stem cells from mice exposed to MTX in the presence of IL-22 neutralizing antibodies. Lgr5-GFP hi crypt cells were analyzed by RNA sequencing one day after MTX. The 
YAP1 activation requires gp130 dimerization and Src family kinase activation
Damage-induced epithelial YAP1 activation can occur in response to a variety of stimuli, including signaling through the IL-6 family receptor gp130 and mechanotension in response to altered extracellular matrix composition (Taniguchi et al., 2015) . Mechanotension-induced YAP1 activation occurs during the later stages of tissue repair and involves activation of a discrete set of genes (Yui et al., 2018) . Analyses of these mechanotension-associated genes in Lgr5-GFP hi stem cells after MTX-induced damage showed that these genes are either not transcribed or transcribed at similar levels in ILC3-deficient and control mice ( Figure S4A-B) ,
making it unlikely that this pathway is important during the initial ILC3-depemdent activation of epithelial YAP1.
In order to define whether ILC3-driven YAP1 involved gp130 signaling we first analyzed the transcriptome of Lgr5-GFP hi small intestinal crypt cells for presence of gp130 and the cytokinespecific receptor chains that multimerize with gp130 to form functional receptor units. Under homeostatic conditions, as well as after damage, Lgr5-GFP hi crypt cells transcribed gp130, the il11ra1 chain, and low levels of Cntfr ( Figure 4G) . IL-6 can also signal via a soluble IL-6R that complexes with gp130, thereby precluding the necessity for cell-autonomous IL-6R
transcription (Novick et al., 1989) . The IL-6 and IL-11 pathways have been associated with multiple aspects of tissue regeneration, and alterations in these pathways are linked to IBD susceptibility and intestinal cancer progression (Garbers and Scheller, 2013; Katsanos and Papadakis, 2017; Taniguchi and Karin, 2014) . The IL-6 and IL-11 receptors utilize homodimerization of gp130 to form a specific receptor with a single IL-6R or IL-11R chain. To analyze possible involvement in Yap1 activation of gp130 homo-dimerization we used a small molecule inhibitor of this process (LMT-28) (Hong et al., 2015) . LMT-28 application during the induction of small intestinal damage with MTX reduced nuclear translocation of YAP1 in crypt epithelial cells, reduced the percentage of crypts containing at least one cell with nuclear YAP1
per transverse section, and thus increased the number of crypts that failed to activate YAP1driven regeneration ( Figure 4H) . Downstream of gp130-associated receptors signals are transduced by either STAT3 signaling or by activation of Src family kinases (SFKs) (Taniguchi et al., 2015) . To assess the importance of these two pathways we inhibited STAT2/3 signaling with the small molecule inhibitor STATTIC and SFK activity with the pharmacological inhibitor PP2. Efficiency of STAT inhibition was controlled by analyses of known STAT3 target genes ( Figure S4C ). Inhibition of STAT3 signaling also blocks IL-22 receptor signaling highlighted by the failure of Lgr5 + stem cell maintenance following MTX damage ( Figure 4C) . In contrast, the YAP1-dependent proliferative response at day 4 post MTX was not affected by STAT2/3 inhibition ( Figure 4D) indicating that STAT molecules are not involved in this process.
Administration of the SFK inhibitor PP2 prevented nuclear translocation of YAP1 in small intestinal crypt cells ( Figure 4E) and resulted in increased crypt pathology and loss of crypt proliferation ( Figure 4F) , reminiscent of the regenerative defects in ILC3-deficient RORgt -/mice. These findings again highlight the dichotomy between stem cell maintenance, which is both ILC3 and IL22-dependent, and crypt proliferation that is ILC3-dependent yet IL22independent.
Collectively, our findings reveal that the evolutionary conserved, regeneration-associated Hipo-YAP1 signaling pathway is amplified by presence of ILC3, independent of the stem cellprotective effect of IL-22. This implies that immune cell-driven tissue regeneration is the sum of multiple parallel pathways, including the well-established IL22R signaling pathway as well as ILC3-dependent YAP1 activation as shown in this report. The mechanistic uncoupling of stem cell protection and crypt regeneration could suggest that ILC3 act on not only on LGR5expressing intestinal progenitors, but also on additional damage-associated epithelial precursor subsets (Ayyaz et al., 2019; Tian et al., 2011) .
YAP1-driven intestinal regeneration is critical for epithelial proliferation after intestinal damage
in insects (Karpowicz et al., 2010; Ren et al., 2010; Shaw et al., 2010) . Nevertheless, ILC3
are present only in mammals and fish (Hernandez et al., 2018) , and are lacking from more primitive organisms (Lane et al., 2009) . Combined with our findings, this implies that evolution favored a complementary layer of crypt regulation driven by specialized innate immune cells.
This paves the way for future design of novel targeting strategies aimed at activating ILC3driven tissue repair in IBD or reduce side effects of anti-cancer therapies, independent of IL- 
22.
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METHODS
Mice
Crypt isolation. Isolation of intestinal crypts was performed as previously described (Sato et al., 2009) . Briefly, isolated small intestines were opened longitudinally and washed with cold PBS. 5 mm pieces were washed with cold PBS, incubated in EDTA (2 mM) at 4°C for 30 min and resuspended in PBS. Crypt-enriched sediments were passed through a 70 μm cell strainer and centrifuged at 200 g for 2 min to separate the crypts from single cells. Crypts were incubated with 1 ml of TrypLE Express (Gibco) + Dnase I (Merk Millipore) at 37°C for 10-15 min until crypt dissociation was observed. Single cell suspensions were filtered through 40 μm cell strainer and labeled with conjugated antibodies.
Antibodies. The following antibodies were used for flow cytometry: CD45 (30F11; Invitrogen);
EpCAM-1 (G8. Alignments against the mouse genome (mm10) and analysis of differential expressed genes were performed with DESeq2 in the R environment on the raw fragment counts extracted from the BAM files by HTSeq-count (Gröschel et al., 2014) . Cufflinks software was used to calculate the number of fragments per kilobase of exon per million fragments mapped (FPKM) for each gene.
Histology. Small intestinal tissue pieces (5 mm) or Swiss rolls were fixed in 4% PFA (4h, room temperature), washed in 70% ethanol and embedded in paraffin. Four-µm sections were deparaffinized and stained with hematoxylin (Vector Laboratories) and eosin (Sigma-Aldrich).
For Ki67 and YAP1 detection, endogenous peroxidases were blocked in 1% periodic acid in deionized water for 20 min, and antigen retrieval was achieved by microwave treatment in citrate buffer (10mM, pH 6.0). Prior to staining, Fc receptors were blocked in 10% normal mouse serum and 10% of normal serum matching the host species of the secondary antibody, 10 mM Tris buffer, 5 mM EDTA, 0.15 M NaCl, 0.25% gelatin, and 0.05% Tween-20 (pH 8.0).
Tissue sections were incubated overnight at 4°C with primary antibodies in PBS supplemented with 2% normal mouse serum. Immunoreactions were detected using biotinylated donkey antirat (Dako) and goat-anti-rabbit (Vector Laboratories) and incubated with the Vectastain ABC Elite Kit (Vector Laboratories) and 3,3'-diaminobenzidine tetrahydrochloride (Sigma-Aldrich).
Sections were counterstained with hematoxylin. Pathology scores and enumeration of Ki67 and Yap1 were performed blinded. Pathology was scored as previously described (de Koning et al., 2006) and Ki67-expressing cells were counted in 7 to 15 crypts per section.
Immunohistochemistry. Tissues were frozen in Tissue-Tek O.C.T compound (Sakura Finetek Europe B.V.) and stored at -80 °C. Six μm cryosections were fixed for 5 min in icecold acetone and air-dried for 10 min, and subsequently blocked with 5% normal mouse serum and 5% normal donkey serum for 15 min. Sections were incubated with primary antibody for 1 hr. at room temperature, followed by a 30min incubation with secondary antibodies. Sections were embedded in Pro-long Gold with DAPI (Invitrogen) and analyzed on a Leica DMRXA. 
